ATE68352T1 - Methode zur behandlung der eisenuebersaettigung. - Google Patents

Methode zur behandlung der eisenuebersaettigung.

Info

Publication number
ATE68352T1
ATE68352T1 AT87310300T AT87310300T ATE68352T1 AT E68352 T1 ATE68352 T1 AT E68352T1 AT 87310300 T AT87310300 T AT 87310300T AT 87310300 T AT87310300 T AT 87310300T AT E68352 T1 ATE68352 T1 AT E68352T1
Authority
AT
Austria
Prior art keywords
iron
supersaturation
treatment
mammal
red blood
Prior art date
Application number
AT87310300T
Other languages
English (en)
Inventor
John William Adamson
Michael Richard Downing
Joseph Wetherill Eschbach
Joan Christine Egrie
Original Assignee
Kirin Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc
Application granted granted Critical
Publication of ATE68352T1 publication Critical patent/ATE68352T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Manufacture Of Iron (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Hydrogen, Water And Hydrids (AREA)
  • Compounds Of Iron (AREA)
AT87310300T 1986-11-21 1987-11-20 Methode zur behandlung der eisenuebersaettigung. ATE68352T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/933,495 US5013718A (en) 1986-11-21 1986-11-21 Method for treating iron overload using EPO
EP87310300A EP0269394B1 (de) 1986-11-21 1987-11-20 Methode zur Behandlung der Eisenübersättigung

Publications (1)

Publication Number Publication Date
ATE68352T1 true ATE68352T1 (de) 1991-11-15

Family

ID=25464076

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87310300T ATE68352T1 (de) 1986-11-21 1987-11-20 Methode zur behandlung der eisenuebersaettigung.

Country Status (16)

Country Link
US (1) US5013718A (de)
EP (1) EP0269394B1 (de)
JP (1) JPH0692316B2 (de)
KR (1) KR950009100B1 (de)
AT (1) ATE68352T1 (de)
AU (1) AU602028B2 (de)
CA (1) CA1322165C (de)
DE (1) DE3773852D1 (de)
DK (1) DK167650B1 (de)
ES (1) ES2039252T3 (de)
GR (1) GR3003254T3 (de)
IE (1) IE60865B1 (de)
IL (1) IL84275A (de)
NZ (1) NZ222432A (de)
PT (1) PT86187B (de)
WO (1) WO1988003808A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2858752B2 (ja) * 1987-04-10 1999-02-17 オーソ・フアーマシユーチカル・コーポレーシヨン 正常な哺乳動物のヘマトクリツト値の増大方法
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US6012450A (en) * 1993-01-29 2000-01-11 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
DE69531952T2 (de) 1994-11-03 2004-07-29 Roche Diagnostics Gmbh Verwendung des erythropoietins zur behandlung von rheumatoider arthritis
JPH11502845A (ja) 1995-03-31 1999-03-09 アラディグム コーポレーション 造血剤の肺内輸送
TW586933B (en) * 1996-06-20 2004-05-11 Chugai Pharmaceutical Co Ltd Compositions for treating liver-complaints using EPO
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
EP0965349A1 (de) * 1998-06-18 1999-12-22 Roche Diagnostics GmbH Verwendung von Erythropoietin zur Behandlung von Hämochromatosen
AR019025A1 (es) 1998-04-09 2001-12-26 Roche Diagnostics Gmbh Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado
US6210924B1 (en) 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
DE19857609A1 (de) * 1998-12-14 2000-06-15 Hannelore Ehrenreich Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
WO2001035095A2 (en) * 1999-11-12 2001-05-17 Rothenberg Barry E Diagnostic test for hemochromatosis
US7160855B2 (en) * 2002-03-14 2007-01-09 Children's Hospital & Research Center At Oakland Enhancement of iron chelation therapy
DE10234192B4 (de) 2002-07-26 2009-11-26 Epoplus Gmbh Co.Kg Verwendung von Erythropoetin
ES2343518T3 (es) * 2002-09-09 2010-08-03 Hanall Biopharma Co., Ltd. Polipeptidos interferon alfa modificados resistentes a proteasas.
EP2120998B1 (de) 2006-11-28 2013-08-07 HanAll Biopharma Co., Ltd. Modifizierte erythropoetin-polypeptide und ihre verwendungen zur behandlung
US10694961B2 (en) * 2011-06-13 2020-06-30 Cedaris-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
US10694962B2 (en) 2011-06-13 2020-06-30 Cedars-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
FR3037592B1 (fr) 2015-06-18 2017-06-09 Michelin & Cie Pneumatique pourvu d'une bande de roulement comprenant un elastomere dienique et un systeme d'elastomeres thermoplastiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4667016A (en) * 1985-06-20 1987-05-19 Kirin-Amgen, Inc. Erythropoietin purification

Also Published As

Publication number Publication date
EP0269394B1 (de) 1991-10-16
WO1988003808A1 (en) 1988-06-02
DK407488D0 (da) 1988-07-21
AU602028B2 (en) 1990-09-27
CA1322165C (en) 1993-09-14
IE873113L (en) 1988-05-21
IL84275A (en) 1993-04-04
DK407488A (da) 1988-07-21
JPH0692316B2 (ja) 1994-11-16
IE60865B1 (en) 1994-08-24
EP0269394A2 (de) 1988-06-01
KR950009100B1 (ko) 1995-08-14
DK167650B1 (da) 1993-12-06
PT86187B (pt) 1990-11-07
DE3773852D1 (de) 1991-11-21
EP0269394A3 (en) 1988-09-14
GR3003254T3 (en) 1993-02-17
KR890700032A (ko) 1989-03-02
PT86187A (en) 1987-12-01
JPS63159322A (ja) 1988-07-02
ES2039252T3 (es) 1993-09-16
US5013718A (en) 1991-05-07
AU8179487A (en) 1988-06-16
NZ222432A (en) 1990-07-26

Similar Documents

Publication Publication Date Title
ATE68352T1 (de) Methode zur behandlung der eisenuebersaettigung.
RU93052390A (ru) Способ лечения шизофрении, применение комбинации арахидоновой и докозагексановой кислот для получения лекарственного средства для лечения шизофрении
ES2007341A6 (es) Un procedimiento para producir m-csf
NO880929L (no) Produksjon og bruk av il-6.
NO881819D0 (no) Forenklet fremgangsmaate for fremstilling av humane lymfokinaktivate drepeceller.
EP0179390A3 (de) L-Lysin- und L-Histidinpyruvat
FR2314729A1 (fr) Solution injectable d'hemoglobine ne renfermant pas de stroma et procede de sa preparation
ATE70978T1 (de) Zusammensetzung zur erhoehung des haematokrits bei einem normalen saeugetier.
BG51041A3 (en) Process for the preparation of (s)- alpha- ethyl- 2- oxo- 1- pyrrolidineacetamide
FR2559781B3 (fr) Nouveau vecteur plasmidique hybride de e. coli conferant le pouvoir de faire fermenter le saccharose et son procede de preparation
IT8220954A0 (it) Composti attivi nel trattamento dell'ulcera e di sintomi allergici della pelle
AT345265B (de) Verfahren zur herstellung von reiner traubensaeure und von mesoweinsaeure
OA09455A (fr) Nouveaux polyols furanniques, utilisation de ceux-ci comme polyols dans la formation de polyuréthannes, polyuréthannes ainsi obtenus et leur procédé de préparation.
SE429091B (sv) Forfarande for behandling av cellprotein for att reducera halten nukleinsyra i cellerna
DK299585A (da) Fremgangsmaade til behandling af syreholdige afgangsgasser
ES8706110A1 (es) Un procedimiento para la preparacion de derivados de alfa-aminoalquil-alfa-alquilfenilacetonitrilo.
FR2582654B1 (fr) Steroides 11b-substitues utiles notamment dans le traitement des tumeurs hormono-dependantes et procede pour la fabrication
PH23658A (en) Improved method of treating tumors with autologous lymphokine activated killer,interleukin-2 and an ornithine decarboxylase inhibitor
ATE110278T1 (de) Verfahren und zubereitung für die behandlung von hiv-infizierten säugetieren.
FR2558481B1 (fr) Procede de preparation de l'acide 4-amino-3-hydroxybutyrique optiquement actif
IT8509310A0 (it) Metodo rapido di prova per determinare la sedimentazione del sangue venoso
FR2549390B1 (fr) Procede de retention d'un corps dissous dans une solution
SU584001A1 (ru) Способ регенерации этилендиаминтетрауксусной кислоты и меди их меднотрилоновых растворов
SU568633A1 (ru) Способ получени серосодержащих эфиров 2,4-дихлорфеноксиуксусной кислоты
JPS6480286A (en) Method for purifying enzyme

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time